Article info
Clinical and epidemiological research
Extended report
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study
- Correspondence to Dr Lene Dreyer, Center for Rheumatology and Spine Diseases, Rigshospitalet, Gentofte University Hospital, Hellerup 2900, Denmark; lene.dreyer{at}regionh.dk
Citation
Risk of second malignant neoplasm and mortality in patients with rheumatoid arthritis treated with biological DMARDs: a Danish population-based cohort study
Publication history
- Received July 17, 2017
- Revised October 30, 2017
- Accepted November 20, 2017
- First published December 7, 2017.
Online issue publication
March 12, 2018
Article Versions
- Previous version (7 December 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.